NBC Securities Inc. boosted its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 112,160.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,613 shares of the company's stock after purchasing an additional 5,608 shares during the quarter. NBC Securities Inc.'s holdings in Colgate-Palmolive were worth $525,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its position in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after buying an additional 450 shares during the last quarter. Sargent Investment Group LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth about $209,000. Bernard Wealth Management Corp. bought a new position in Colgate-Palmolive during the fourth quarter valued at about $36,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Colgate-Palmolive by 20.1% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 157,811 shares of the company's stock valued at $14,402,000 after acquiring an additional 26,382 shares in the last quarter. Finally, Choreo LLC raised its holdings in Colgate-Palmolive by 17.9% in the 4th quarter. Choreo LLC now owns 27,563 shares of the company's stock valued at $2,503,000 after acquiring an additional 4,190 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.
Analysts Set New Price Targets
Several brokerages have recently weighed in on CL. Barclays decreased their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. UBS Group lifted their price target on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. Citigroup boosted their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday, April 28th. Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. Finally, Wall Street Zen lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $102.12.
Get Our Latest Report on CL
Colgate-Palmolive Price Performance
Shares of CL traded up $0.03 on Friday, hitting $90.18. The company's stock had a trading volume of 4,716,460 shares, compared to its average volume of 4,712,088. The company has a market capitalization of $73.08 billion, a PE ratio of 25.62, a PEG ratio of 4.20 and a beta of 0.38. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a 50 day moving average price of $91.84 and a 200 day moving average price of $91.21. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The business's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.86 EPS. On average, research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive declared that its Board of Directors has authorized a share buyback program on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.
Colgate-Palmolive Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.31%. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is currently 58.76%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.